1184 related articles for article (PubMed ID: 34335633)
41. BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer.
Yuanming L; Lineng Z; Baorong S; Junjie P; Sanjun C
BMC Cancer; 2013 Mar; 13():103. PubMed ID: 23496813
[TBL] [Abstract][Full Text] [Related]
42. A prognostic model based on tumor microenvironment and immune cell in colorectal cancer.
Lin Y; Chen Y; Gan L; Li Z; Shen F
Scand J Gastroenterol; 2024 Mar; 59(3):304-315. PubMed ID: 37978827
[TBL] [Abstract][Full Text] [Related]
43. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
44. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
45. Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes.
Zhuang A; Zhuang A; Chen Y; Qin Z; Zhu D; Ren L; Wei Y; Zhou P; Yue X; He F; Xu J; Ding C
Elife; 2023 May; 12():. PubMed ID: 37158593
[TBL] [Abstract][Full Text] [Related]
46. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer.
Huang A; Sun Z; Hong H; Yang Y; Chen J; Gao Z; Gu J
J Transl Med; 2024 Jun; 22(1):587. PubMed ID: 38902737
[TBL] [Abstract][Full Text] [Related]
47. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
[TBL] [Abstract][Full Text] [Related]
48. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
49. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
50. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer.
Wang L; Chen X; Zhang H; Hong L; Wang J; Shao L; Chen G; Wu J
Front Immunol; 2022; 13():1014834. PubMed ID: 36389750
[TBL] [Abstract][Full Text] [Related]
53. Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis.
Wang L; Liu D; Liu S; Liao T; Jiao Y; Jiang X; Wang Y; Chen Y; Ma H; Cai H
Transl Oncol; 2022 Jul; 21():101435. PubMed ID: 35483170
[TBL] [Abstract][Full Text] [Related]
54. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract][Full Text] [Related]
55. Exosomal MEF2C's Association With the Progression of CRC in Regulating CD36 Transcription.
Wang M; Jiang Y; Fan ZL; Zhang N; Liang J; Zheng Z
Altern Ther Health Med; 2023 Jan; 29(1):198-209. PubMed ID: 36074971
[TBL] [Abstract][Full Text] [Related]
56. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma.
Yang C; Huang S; Cao F; Zheng Y
BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325
[TBL] [Abstract][Full Text] [Related]
57. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
[TBL] [Abstract][Full Text] [Related]
58. ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.
Huang Z; Hu X; Wei Y; Lai Y; Qi J; Pang J; Huang K; Li H; Cai P
PLoS One; 2024; 19(5):e0303909. PubMed ID: 38814950
[TBL] [Abstract][Full Text] [Related]
59. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer.
Li C; Chen S; Fang X; Du Y; Guan XY; Lin R; Xu L; Lan P; Yan Q
Cell Biol Toxicol; 2024 Jan; 40(1):6. PubMed ID: 38267662
[TBL] [Abstract][Full Text] [Related]
60. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]